<DOC>
	<DOCNO>NCT01098305</DOCNO>
	<brief_summary>This study , base India , test efficacy varenicline help smokeless tobacco user cessation effort .</brief_summary>
	<brief_title>Efficacy Varenicline Smokeless Tobacco Use India</brief_title>
	<detailed_description>The prevalence smokeless tobacco use United States low vs. cigarette smoking , yet rate remain constant past year . In contrast , rate smokeless tobacco use India 20 % . Smokeless tobacco carcinogenic responsible ~10,000 deaths/year oral cancer India . Unfortunately , remarkably intervention trial India smokeless tobacco user . To date , trial evaluate new FDA approve medication , varenicline , smokeless tobacco use . We conduct randomize placebo-controlled trial varenicline smokeless tobacco dependence National Drug Dependence Treatment Center ( NDDTC ) All India Institute Medicine ( AIIMS ) New Delhi 237 smokeless tobacco user . The primary aim trial : 1 ) enhance research capacity NDDTC ( i.e. , train AIIMS staff implement behavioral counseling protocol pharmacotherapy , data collection management procedure ) ; 2 ) ass efficacy varenicline increase biochemically confirm 7-day point prevalence smokeless tobacco quit rate end-of treatment ; 3 ) ass longitudinal pattern relapse recovery follow treatment varenicline . The result trial may guide future investment evaluate efficacy varenicline smokeless tobacco dependence US , critical since smokeless tobacco use US may increase come year approve pharmacotherapy drug dependence exist US around globe .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>male female age 18 use smokeless tobacco every day past year ( confirm urinary cotinine ) reside within 100km New Dehli next 4 month interested quit use smokeless tobacco . currently enrol plan enroll another tobacco cessation program next 4 month plan use smoke cessation treatment next 4 month smoke cigarette current substance abuse ( e.g. , opioids , cocaine , marijuana ) verify urine drug screen current ( last 6months ) alcohol consumption exceed 25 standard drinks/week ( past abuse , must symptom free ≥ past 12 month ) Current use discontinuation within last 14 day : 1. smoke cessation medication ( bupropion , Varenicline , NRT ) ; 2. antipsychotic , atypicals , moodstabilizers , antidepressant ( tricyclic , SSRIs , MAOIs ) , antipanic agent , antiobsessive agent , antianxiety agent , stimulant ; 3 . Anticoagulants ; 4 . Daily medication asthma diabetes ( eligible physician approval ) ; pregnant , planning pregnancy , lactate history current diagnosis psychosis , general anxiety disorder , bipolar disorder , schizophrenia current diagnosis depression ( past diagnosis , must symptom free ≥ past 12 month ) allergy Varenicline ever contemplate attempted suicide serious/unstable disease within past 6 month ( e.g. , cancer [ melanoma ] , heart disease , HIV/AIDS ) history epilepsy seizure disorder history diagnosis within last 6 month abnormal rhythms and/or tachycardia ( &gt; 100 beats/minute ) history current diagnosis COPD ; cardiovascular disease ( stroke , angina ) ; heart attack last 6 month ; and/or uncontrolled hypertension ( SBP &gt; 150 DBP &gt; 90 ) 16 ) history kidney liver failure medical condition medication could compromise safety determine study physician provide inform consent complete study task determine Principal Investigator study physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>nicotine smokeless tobacco chew tobacco varenicline</keyword>
</DOC>